共 50 条
- [1] Radiation therapy as bridging and salvage strategy among patients with secondary central nervous system lymphoma undergoing CD19-targeted CAR T-cell therapyAMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2024, 47 (10): : S30 - S31Ababneh, HazimFrigault, MatthewNg, AndreaPatel, Chirayu
- [2] Outcomes of patients with primary central nervous system lymphoma following CD19-targeted chimeric antigen receptor T-cell therapyHAEMATOLOGICA, 2025, 110 (01) : 218 - 221Mercadal, SantiagoAhn, Kwang WooAllbee-Johnson, MariamGanguly, SiddharthaGeethakumari, Praveen RamakrishnanHong, SangheeMalone, AdrianaMurthy, HemantPawarode, AttapholSica, R. AlejandroSolh, MelhemUstun, CelalettinShadman, MazyarSauter, Craig S.Hamadani, MehdiHerrera, Alex F.Lee, Catherine J.
- [3] Prognostic Factors for High-Grade B Cell Lymphoma Patients Treated With Commercial CD19-Targeted CAR T-Cell TherapyCLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S354 - S355Ababneh, Hazim S.Frigault, Matthew J.Patel, Chirayu G.
- [4] Radiation therapy as bridging and salvage strategy among patients with secondary central nervous system lymphoma undergoing CD19-targeted chimeric antigen receptor T-cell therapyHEMATOLOGICAL ONCOLOGY, 2024, 42 (01)Ababneh, Hazim S.Frigault, Matthew J.Ng, Andrea K.Patel, Chirayu G.
- [5] Monocytes in leukapheresis products affect the outcome of CD19-targeted CAR T-cell therapy in patients with lymphomaBLOOD ADVANCES, 2024, 8 (08) : 1968 - 1980Carniti, CristianaCaldarelli, Nicole M.Agnelli, LucaTorelli, TommasoLjevar, SilvaJonnalagadda, SadhanaZanirato, GiadaFardella, EugenioStella, FedericoLorenzini, DanieleBrich, SilviaArienti, FlavioDodero, AnnaChiappella, AnnalisaMagni, MartinaCorradini, Paolo
- [6] NEUROTOXICITY RELATED TO CAR T-CELL THERAPY IN PATIENTS WITH SECONDARY CENTRAL NERVOUS SYSTEM LYMPHOMANEURO-ONCOLOGY, 2021, 23 : 147 - 147Yuen, CarlenWesley, SarahVan Besien, KoenHsu, Jing-MeiReshef, RanIwamoto, FabioHaggiagi, AyaMagge, Rajiv
- [7] Outcomes of Bridging and Salvage Radiotherapy in Relapsed or Refractory Mantle Cell Lymphoma Patients Undergoing CD19-Targeted CAR T-Cell TherapyINTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 117 (02): : E456 - E456Ababneh, H.Frigault, M.Patel, C. G.
- [8] Clinical and Product Features Associated with Outcome of DLBCL Patients to CD19-Targeted CAR T-Cell TherapyCANCERS, 2021, 13 (17)Lamure, SylvainVan Laethem, FrancoisDe Verbizier, DelphineLozano, ClaireGehlkopf, EveTudesq, Jean-JacquesSerrand, ChrisBenzaoui, MehdiKanouni, TarikQuintard, AdelineDe Vos, JohnTchernonog, EmmanuellePlaton, LauraAyrignac, XavierCeballos, PatriceSirvent, AnneFrancois, MickaelGuedon, HananeQuittet, PhilippeMongellaz, CedricConte, AurelieHerbaux, CharlesBret, CarolineTaylor, NaomiDardalhon, ValerieCartron, Guillaume
- [9] Outcomes of patients with secondary central nervous system lymphoma following CAR T-cell therapy: a multicenter cohort studyJOURNAL OF HEMATOLOGY & ONCOLOGY, 2023, 16 (01)Epperla, NarendranathFeng, LeiShah, Nirav N.Fitzgerald, LindseyShah, HarshStephens, Deborah M.Lee, Catherine J.Ollila, ThomasShouse, GeoffreyDanilov, Alexey V.David, Kevin A.Torka, PallawiHashmi, HamzaHess, BrianBarta, Stefan K.Romancik, Jason T.Cohen, Jonathon B.Annunzio, KaitlinKittai, Adam S.Reneau, JohnZurko, JoannaNizamuddin, Imran A.Winter, Jane N.Gordon, Leo I.Ma, ShuoPatel, RomilNastoupil, LorettaAhmed, SairahKarmali, Reem
- [10] Outcomes of patients with secondary central nervous system lymphoma following CAR T-cell therapy: a multicenter cohort studyJournal of Hematology & Oncology, 16Narendranath EpperlaLei FengNirav N. ShahLindsey FitzgeraldHarsh ShahDeborah M. StephensCatherine J. LeeThomas OllilaGeoffrey ShouseAlexey V. DanilovKevin A. DavidPallawi TorkaHamza HashmiBrian HessStefan K. BartaJason T. RomancikJonathon B. CohenKaitlin AnnunzioAdam S. KittaiJohn ReneauJoanna ZurkoImran A. NizamuddinJane N. WinterLeo I. GordonShuo MaRomil PatelLoretta NastoupilSairah AhmedReem Karmali